|
Issue |
Title |
|
No 16 (2019) |
Associations of aldosterone synthase gene polymorphism and atrial fibrillation affected by coronary heart disease in elderly and senile patients |
Abstract
PDF (Rus)
|
L. I. Kudryavtseva, E. V. Filippov |
|
No 5 (2019) |
Anticoagulant therapy and components of the metabolic syndrome in patients with atrial fibrillation in real outpatient clinical practice |
Abstract
PDF (Rus)
|
V. A. Ionin, E. Yu. Petrischeva, D. S. Skuridin, O. I. Bliznyuk, A. A. Ivanova, A. E. Filatova, I. Ma., E. L. Zaslavskaya, E. I. Baranova |
|
No 5 (2019) |
Possibilities for correcting endothelial dysfunction in patients with arterial hypertension and coronary heart disease |
Abstract
PDF (Rus)
|
E. V. Filippov |
|
No 16 (2018) |
А new drug in the complex therapy of diabetes mellitus. Post-registration experience in patients with type 1 and type 2 diabetes mellitus |
Abstract
PDF (Rus)
|
S. V. Vorob'yev, E. U. Petrovskaya, N. A. Kuz'menko, I. A. Khripun |
|
No 16 (2018) |
Evaluation of the effect of taurine on the course of coronary artery disease associated with diabetes of the 2nd type, in patients undergoing coronary revascularization |
Abstract
PDF (Rus)
|
A. V. Svarovskaya, A. A. Garganeeva |
|
No 16 (2018) |
Use of sodium-glucose co-transporter-2 inhibitors from clinical trial results to practical application in Russia |
Abstract
PDF (Rus)
|
D. A. Lebedev, A. Yu. Babenko |
|
No 5 (2018) |
Elderly patient with atrial fibrillation and comorbid pathology: therapeutic potential of dabigatrane administration |
Abstract
PDF (Rus)
|
D. A. Napalkov, A. A. Sokolova |
|
No 5 (2018) |
Basic principles of primary prevention of type 2 diabetes mellitus |
Abstract
PDF (Rus)
|
R. N. Shepel |
|
No 5 (2018) |
Anticoagulant therapy in the management of patients with atrial fibrillation from the viewpoint of comorbidities: focus on choice |
Abstract
PDF (Rus)
|
O. D. Ostroumova, A. A. Zykova, I. V. Goloborodova, A. I. Kochetkov, G. F. Piksina |
|
1 - 9 of 9 Items |
|